Product Images Ranolazine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ranolazine NDC 73141-022 by A2a Integrated Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemicalstructure - chemicalstructure
container-1000mg-60tablets - container 1000mg 60tablets
This is a description of Ranolazine Extended-Release Tablets, with each tablet containing 1,000 mg of ranolazine. The instruction advises swallowing the tablet whole, not crushing, breaking, or chewing it. It is a prescription medication, and the package includes 60 tablets. The usual dosage information can be found in the package insert. The tablets should be stored at 25°C (77°F) with excursions allowed between 15-30°C (59-86°F). The package is child-resistant and should be kept out of children's reach. The tablets are film-coated and manufactured by A2A Integrated Pharmaceuticals.*
container-500mg-60tablets - container 500mg 60tablets
This is a description of Ranolazine Extended-Release Tablets with a dosage of 500 mg per tablet. It contains important instructions such as swallowing the tablet whole and not crushing, breaking, or chewing it. The usual dosage information can be found in the package insert. Storage instructions recommend keeping the tablets at 25°C; excursions between 15° to 30°C are acceptable. The packaging is child-resistant and should be kept out of reach of children. The tablets are distributed by A2A Integrated Pharmaceuticals.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
